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ABSTRACT
Introduction. Anterior cruciate ligament (ACL) injuries are common 
and reconstruction can be completed with either autograft or allograft 
tissue. However, there is concern about an increased failure rate with 
allograft tissue. The purpose of this study was to systematically review 
the available evidence to determine the effect of irradiation and level 
of dose on the failure rates of allograft in ACL reconstruction.
Methods.xA literature search was performed using PubMed, Scopus, 
and Web of Science from January 2000 to September 2013. Inclusion 
criteria consisted of the following: (1) primary, unilateral, single-
bundle allograft ACL procedure, (2) studies with data documenting 
graft type and terminal sterilization technique, (3) subjective assess-
ments of outcome, and (4) objective assessments of outcome. Studies 
without reported subjective and objective outcomes and those per-
taining to revision ACL reconstruction were excluded. Failures were 
defined and compared between irradiated and non-irradiated grafts, 
as well as between grafts irradiated with 1.2 - 1.8 Mrad and those with 
2.0 - 2.5 Mrad.
Results. Of the 242 articles identified via initial search, 17 studies met 
the final inclusion criteria. A total of 1,090 patients were evaluated in 
this study, all having undergone unilateral primary ACL reconstruc-
tion with allograft tissue with 155 failures. The failure rate between 
non-irradiated (98/687, 14.7%) and irradiated (57/408, 14.0%) was 
not statistically significant (p = 0.86). Grafts in the high-dose irra-
diation group (27/135, 20.0%) had a statistically significant higher (p 
< 0.001) rate of failure than those in the low-dose irradiation group 
(30/273, 10.6%).
Conclusion. The irradiation of an allograft increases the risk of failure 
after an ACL reconstruction but the use of lower doses of radiation 
decreases that risk. Kans J Med 2020;13:23-28.
INTRODUCTION
  Anterior cruciate ligament (ACL) injuries are common and recon-
struction can be completed with either autograft or allograft tissue. 
One study showed that the allograft in primary reconstruction had 
increased between 2002 and 2008.1 The benefits of using allograft 
for ACL reconstruction are numerous and include shorter operative 
times, increased availability, and graft selection options, as well as 
decreased incidence of postoperative arthrofibrosis. In addition, there 
is no risk of donor site morbidity and complications, such as anterior 
knee pain, loss of knee extension, and loss of knee flexion strength, are 
avoided. 
 One of the disadvantages of using allograft tissue is a higher report-
ed rate of graft failure. Different studies have shown rates of failure up 
to three times higher in patients who underwent ACL reconstruction 
with allograft compared to autograft.2,3 Another disadvantage is the 
possibility of disease transmission from the allograft, although the 
risk is very low. Estimates of viral transmission risk from unprocessed 
tissues that are nucleic acid amplification test negative is 1 in 173,000 
for human immunodeficiency virus (HIV), 1 in 421,000 for Hepatitis 
C, and 1 in 100,000 for Hepatitis B.4 Fresh-frozen, freeze-drying, or 
cryopreservation are the different ways an allograft initially can be 
processed. These techniques reduce the graft’s immunogenicity but 
do not eradicate the chance of bacterial or viral transmission. Donor 
screening procedures, such as the exclusion of high-risk groups and 
serologic testing, also reduce the risk of disease transmission. Despite 
the low risk of transmission, secondary sterilization of the graft often 
is completed. Ethylene oxide is no longer used due to higher graft 
failure rates5 and reports of chronic synovitis.6 Low-dose gamma 
irradiation between 1.0 and 2.5 Mrad is the accepted protocol for sec-
ondary sterilization by most tissue banks, as high levels (> 4.0 Mrad) 
have been shown to weaken the properties of the allograft.7 However, 
up to 5.0 Mrad is necessary to inactivate viruses, such as HIV,8,9 so the 
transmission risk is never eliminated completely.
 The effect of graft sterilization on outcomes of ACL reconstruction 
has not been well studied. The purpose of this study was to system-
atically review and evaluate the available evidence to determine the 
effect of irradiation and different doses of irradiation on the failure 
rates of allograft in ACL reconstruction.
METHODS
 A literature search was performed using PubMed, Scopus, and Web 
of Science from January 2000 to September 2013. Keywords used 
in this search were: anterior cruciate ligament, ACL, reconstruction, 
allograft, irradiated, non-irradiated, and surgery. This search resulted 
in 242 unique articles.
 For our analysis, therapeutic prospective and retrospective studies 
were selected. The inclusion criteria consisted of the following: (1) 
primary, unilateral, single-bundle allograft ACL procedure, (2) 
studies with data documenting graft type and terminal sterilization 
technique, (3) subjective assessments of outcome, and (4) objective 
assessments of outcome. Studies without reported subjective and 
objective outcomes and those pertaining to revision ACL reconstruc-
tion were excluded.
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irradiation level, demographic data, and subjective and objective 
outcome assessments. Demographics included age, gender, mean 
follow-up, and time to failure when reported. 
Subjective outcome assessments included International Knee 
Documentation Committee (IKDC), Lysholm, Tegner, and Cincin-
nati knee scores. Objective outcome assessments included functional 
IKDC scores, Lachman examination, Anterior Drawer test, Pivot shift 
test, instrumented laxity measurements with a KT-1000 arthrometer, 
and graft rupture and revision rates.
Failure rates, when not explicitly defined and reported in a study, 
were based on criteria determined by the authors, who defined failure 
as graft rupture, surgical revision, subjective IKDC score less than 80, 
Tegner Lyholm knee score less than 65, functional IKDC score of C/D 
corresponding to abnormal/severely abnormal, or laxity resulting in 
anterior translation greater than 5 mm measured via either KT-1000 
arthrometer or Lachman examination. Whenever possible, or when 
failures rates varied between criteria, this study used functional IKDC 
scores, arguing that the patient reported outcome (PRO) more accu-
rately reflects how well the patient is doing clinically.
Statistical Analysis. Data were analyzed using a Chi-square test in 
assessing relationships between irradiated and non-irradiated grafts, 
along with low-dose radiation (1.2 - 1.8 Mrad) and higher dose (2.0 - 
2.5 Mrad) with regard to failure. An alpha probability of 0.05 was used 
as the threshold for statistical significance in two-tailed comparisons. 
Means are presented with standard deviations. All statistics were per-
formed with Stata v. 12 (Stata Corp., College Station, TX).
RESULTS
Of the 242 articles identified via initial search, 120 studies were 
excluded by title because it illustrated that the study did not meet the 
inclusion criteria. Three reviewers analyzed the remaining 126 studies 
independently. Of these, 22 studies met initial inclusion criteria. Upon 
further review, four of these studies were excluded for failing to dif-
ferentiate between terminal sterilization techniques when reporting 
graft failures, and one other study failed to note the graft type when 
reporting failure rates. 
Seventeen studies eventually met the final inclusion criteria. With 
the exception of two studies,10,11 minimum follow-up was 24 months. 
In a study by Gorschewsky et al.,12 outcomes data were included from 
their two-year follow-up only to maintain consistency with other 
studies (Table 1). In total, 1,090 patients were evaluated in this study, 
all having undergone unilateral primary ACL reconstruction with 
allograft tissue with 132 failures. The characteristics are broken down 
by graft type in Table 2.
Terminal sterilization primarily consisted of irradiated and non-
irradiated grafts. Of the non-irradiated allografts, the vast majority 
were fresh frozen tissue. Another study used allografts processed via 
cryopreservation, which was discontinued after report of infections.13 
The study switched to fresh frozen grafts, but the authors did not dif-
ferentiate between terminal sterilization techniques when reporting 
failure rates. 
Seven studies (n = 408) utilized irradiated allografts. Thirteen 
studies14,31-42 (n = 682) utilized non-irradiated allografts. The demo-
graphics for these two groups are seen in Table 3. The failure rate 
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between non-irradiated (14.7%) and irradiated (14.0%) was not sta-
tistically significant (p = 0.86). The characteristics of the failures of 
each group are summarized in Table 4.
The amount of radiation used to sterilize allografts fell into one of 
two categories. Allografts sterilized with 2.0 - 2.5 Mrad of radiation 
were considered high-dose irradiated allografts, and those sterilized 
with 1.2 - 1.8 Mrad were considered low-dose. These two groups 
were compared and the demographics are seen in Table 5. Grafts in 
the high-dose irradiation group had a statistically significant higher 
(20.0%) rate of failure than the low-dose irradiation group (10.6%, 
p < 0.001).
DISCUSSION
The principal result of this study did not find a statistically signifi-
cant difference in failure rates between irradiated and non-irradiated 
grafts. However, when the data were analyzed further and adjusted for 
different levels of radiation, a statistically significant greater amount 
of graft failures was found in the high-dose irradiated group versus 
the low-dose irradiated group. A previous review by Park et al.15 found 
lower clinical outcome scores in low-dose irradiation compared to 
non-irradiated grafts. However, their cutoff for low-dose radiation 
was less than 2.5 Mrad. The difference in outcome scores was not ana-
lyzed, but rather failure rate was compared. In our analysis, when the 
low-dose radiation was divided into different groups, very low radia-
tion (1.2 - 1.8 Mrad) allografts had a statistically significant lower rate 
of failure compared to those between 2.0 Mrad and 2.5 Mrad. 
Using low-dose gamma irradiation (1.5 - 2.5 Mrad) may reduce 
the risk of disease transmission and leave the mechanical properties 
of the graft intact.16 The amount of irradiation needed depends on 
the pathogen that is being treated. This includes 0.5 Mrad for spore 
forming bacteria,17 2.1 Mrad for bacterial spores,18 and 0.8 Mrad for 
yeast and molds.19 Unfortunately, HIV can require anywhere from 
1.520,21 to 4 Mrad22 to be eradicated. Therefore, if using a very low dose 
of radiation (1.2 - 1.8 Mrad) as our study suggests, one would have to 
ensure there was extensive screening and testing to minimize the risk 
of transmission of HIV and hepatitis.
Biomechanical studies have shown that irradiation of greater than 
2.5 Mrad are known to have detrimental effects on graft properties.7,23 
Other biomechanical studies have looked at 2.0 Mrad and have found 
a decrease in tensile strength when compared to non-irradiated con-
trols.23,24 Recently, a study by Yanke et al.25 found that low-dose (1.0 
- 1.2 Mrad) gamma irradiation decreases bone-patellar tendon-bone 
(BTB) graft stiffness by 20%, but it does not affect other failure or 
cyclic parameters. Therefore, they recommended low-dose (1.0 - 1.2 
Mrad) gamma irradiation of central third human BTB allografts and 
concluded that it is not deleterious to pre-implantation biomechani-
cal properties. This biomechanical study’s conclusion was consistent 
with what we found in the literature, which is low-dose radiation (1.2 
- 1.8 Mrad) had a statistically significant lower failure rate than higher 
dose (2.0 - 2.5 Mrad) irradiated allografts.26 
24
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Table 1. Summary of all articles. 
Author Level of Evidence
Total 
Number of 
Patients
Irradiated; Number (%) Non-Irradiated; Number (%)
Definition of 
Failure
Irradiated Failures; 
Number (%)
Non-Irradiated Failures; 
Number (%)
Rappe31 3 75 33/75 (44%) 42/75 (56%) > 5 mm 11/33 (33.3%) 1 (2.4%)
Sun32 1 66 32/66 (48%) 34/66 (52%) > 5 mm 11/32 (34.4%) 3 (8.8%)
Rihn10 3 39 39/39 (100%) 0 > 5 mm 1/39 (2.6%) 0 (0%)
Singhal33 4 69 0 (0%) 69/69 (100%) Rupture 0 (0%) 16 (23.2%)
Smith34 4 19 0 (0%) 19/19 (100%) > 5 mm 0 (0%) 0 (0%)
Shah11 4 144 144/144 (100%) 0 (0%) Rupture 8/19 (5.6%) 0 (0%)
Barrett35 3 78 0 (0%) 78/78 (100%) Revision 0 (0%) 19/78 (24.4%)
Poehling36 2 41 0 (0%) 41/41 (100%) IKDC 0 (0%) 11/41 (26.8%)
Gorchewsky12 2 97 97/97 (100%) 0 (0%) Rupture 20/97 (20.6%) 0 (0%)
Kustos37 3 53 0 (0%) 53/53 (100%) Rupture 0 (0%) 2/53 (3.8%)
Noh38 1 32 0 (0%) 32/32 (100%) IKDC 0 (0%) 6/32 (18.8%)
Kim39 4 131 0 (0%) 131/131 (100%) IKDC 0 (0%) 33 (25.2%)
Li40 3 30 0 (0%) 30/30 (100%) TKLS 0 (0%) 0 (0%)
Noh41 2 67 0 (0%) 67/67 (100%) Lachman 0 (0%) 3/67 (4.5%)
Lawhorn42 2 48 0 (0%) 48/48 (100%) > 5 mm 0 (0%) 0 (0%)
Barber43 3 32 32/32 (100%) 0 (0%) > 5 mm 2/32 (6.3%) 0 (0%)
Sun14 1 69 31/69 (45%) 38/69 (55%) IKDC 4/31 (12.9%) 4/38 (10.5%)
Totals 1,090 408/1,090 (37%) 682/1,090 (63%) 57/408 (14.0%) 98/682 (14.4%)
IKDC: International Knee Documentation Committee
Table 2. Characteristics by graft type. 
Achilles BPTB Tibialis Anterior Hamstring
Average age in years 25.9 31.7 32.2 31
Male gender 62.1% 44.4% 73.6% 79.7%
Mean follow-up in months 39.5 40.2 42.2 42.5
Mean time to failure in months 18.2 19.9 22 NA
Irradiated 177 (40.2%) 200 (54.8%) 0 (0%) 31 (12.9%)
Non-irradiated 263 (59.8%) 165 (45.2%) 216 (13.4%) 38 (10.5%)
Mean lysholm score 90.9 86.8 88.5 88.5
Mean tegner score 5.3 6.1 5.2 7.2
Mean subjective IKDC NA 86.6 90.6 85.5
Functional IKDC A/B 286 (88.3%) 157 (77.7%) 145 (86.8%) 61 (88.4%)
Functional IKDC C/D 38 (11.7%) 41 (20.3%) 21 (12.6%) 8 (11.6%)
BPTB: Bone-Patellar Tendon-Bone; IKDC: International Knee Documentation Committee
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Irradiated (n = 408) Non-Irradiated (n = 682)
Age in years 31.7 29.2
Male 41.9% 57.2%
Female 58.1% 42.8%
Achilles allograft 177 263
BTB allograft 200 165
Tibialis anterior 
allograft 0 216
Hamstring 31 38
Mean follow-up in 
months 33.6 37.8
Mean time to failure 
in months NA 25.3
 
Table 4. Summary of the failure results. 
Irradiated (n = 408) Non-Irradiated (n = 682) p value
Failure: n/Total n 
(percent) 57/408 (14.0%) 98/682 (14.7%)
0.86Rupture 28 (6.9%) 37 (5.4%)
IKDC C/D 5 (1.2%) 57 (8.4%)
Laxity > 5 mm 24 (5.9%) 4 (0.59%)
Mean lysholm score 89.2 89.3 N/A
Mean tegner score 6.8 5.6 N/A
Mean IKDC score 84.7 89.7 N/A
Functional IKDC
A/B: 65/70 (92.9%) 252/309 (81.6%)
N/A
C/D: 5/70 (7.1%) 57/309 (18.4%)
IKDC: International Knee Documentation Committee
Table 5. Summary of results by radiation dosage.
2.0 - 2.5 Mrad
(n = 135)
1.2 - 1.8 Mrad
(n = 273) p value
Age in years 33.6 31.9 N/A
Percent male 78.4% 57.2% N/A
Follow-up in months 33.9 37.8 N/A
Time to failure in 
months 22 25.3 N/A
Failure: n/Total n 
(percent) 27/135 (20%) 30/273 (10.9%)
p <0.001Rupture 0 (0.0%) 28 (10.3%)
IKDC C/D 5 (3.7%) 0 (0.0%)
Laxity > 5 mm 22 (16.3%) 2 (0.73%)
Mean lysholm 90.5 89.3 N/A
Mean tegner 7.4 5.6 N/A
Mean IKDC 87.8 89.7 N/A
Functional IKDC A/B 97/102 (95.1%) 0 (0.0%) N/A
Functional IKDC C/D 5/102 (4.9%) 0 (0.0%) N/A
 IKDC: International Knee Documentation Committee
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Gamma irradiation causes molecules and ions in the allograft to 
undergo excitation and chemical reactions such as cross-linking, 
branching, and grafting.27 This process destroys pathogens but also 
generates free radicals that can compromise the integrity of the 
allograft. Recent studies have investigated the use of free radical 
scavengers to minimize the amount of damage caused by irradiation. 
Thiourea, a free radical scavenger, results in less collagen damage and 
less brittle cortical bone in gamma-irradiated allograft bone tissue.28 
Seto et al.29,30 have shown the radio-protective effects of cross-linking 
with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and 
glucose as well as radical scavengers such as mannitol, ascorbate, 
and riboflavin. These promising data suggested that further studies 
are needed to determine which radio-protective agent can be used to 
maintain the quality of irradiated allograft tissue while also minimiz-
ing the risk of disease transmission.
The limitations of this study include all of the limitations inherent 
to meta-analysis, which depends on the quality of the previous papers. 
In our review, only three papers were included that were level one 
evidence. Therefore, there was a lack of high-level of evidence papers 
among our analyses, which limited the conclusions that can be drawn. 
Due to there being multiple different papers and surgeons, there were 
multiple variables not accounted for between the two groups such as 
surgical technique, graft size, graft tensioning, and rehabilitation. Also, 
with there being multiple authors in the analysis, there was no stan-
dard definition of failure for each study. Therefore, when not explicitly 
defined and reported in a study, failure was defined as a graft rupture, 
surgical revision, subjective IKDC score less than 80, Tegner Lyholm 
knee score less than 65, functional IKDC score of C/D corresponding 
to abnormal/severely abnormal, or laxity resulting in anterior trans-
lation greater than 5 mm measured via either KT-1000 arthrometer 
or Lachman examination. Whenever possible, or when failures rates 
varied between criteria, this study used functional IKDC scores, 
arguing that the patient reported outcome (PRO) more accurately 
reflects how well the patient is doing clinically. Finally, one study44 
looking at BioCleanse was excluded due to the control group not being 
separated by sterilization technique. BioCleanse tissue sterilization 
process is a non-thermal combination of mechanical and chemical 
processes that has been reported to inactivate or remove all sources 
of infectious disease transmission while not compromising the biome-
chanical and physiological properties of allograft bone and soft tissue 
and may be a viable alternative to irradiation but was not able to be 
studied in this systematic review.
CONCLUSIONS
The irradiation of an allograft increases the risk of failure after an 
ACL reconstruction but the use of lower doses of radiation decreases 
the risk of failure.
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